TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?

Author： Zattra Edoardo   Stan Roxana   Russo Irene   Lo Nigro Alessandro   Peserico Andrea   Alaibac Mauro  

Publisher： Future Medicine

ISSN： 1750-743X

Source： Immunotherapy, Vol.5, Iss.8, 2013-08, pp. : 791-794

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis G virus (HGV): where we stand and what to do?

By Ahmed Q. Mughis Uddin  

International Journal of Immunological Studies, Vol. 1, Iss. 3, 2011-08 ,pp. : 255-263

Inderscience Publishers

Access to resources Recommend Favorite

Prognostic biomarkers in colorectal cancer: where do we stand?

By Sagaert Xavier  

Virchows Archiv, Vol. 464, Iss. 3, 2014-03 ,pp. : 379-391

Springer Publishing Company

Access to resources Recommend Favorite

Application of Stem Cells in Cardiology: Where we are and where we are Going

By  

Current Stem Cell Research & Therapy, Vol. 1, Iss. 1, 2006-01 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cells and Cardiac Disease: Where are We Going?

By  

Current Stem Cell Research & Therapy, Vol. 3, Iss. 4, 2008-12 ,pp. : 265-276

Bentham Science Publishers

Access to resources Recommend Favorite

Ex vivo expansion of umbilical cord blood: where are we?

By Aljitawi Omar  

International Journal of Hematology, Vol. 95, Iss. 4, 2012-04 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite